Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk

Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk

Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight. A large new study found that women taking these [...]

Ozempic-class GLP-1 drugs linked to 30% lower breast cancer odds in study of 110,000 women

Researchers have found that women taking GLP-1 medications had about 30% lower odds of breast cancer than women who were not using the drugs. Ozempic, Wegovy, Mounjaro, and Zepbound are already widely known for treating diabetes and for weight loss. Now, a new study suggests that GLP-1 drugs, the class of medications to which they belong, may also be linked to lower odds of breast cancer. The results were initially reported at the American Socie…

University of Pennsylvania Study Finds a Surprising Link Between Ozempic and Breast Cancer Risk

Researchers at the University of Pennsylvania found a striking link between Ozempic and breast cancer risk—but it’s not yet clear what’s driving it.